Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$0.2 - $0.5 $2,842 - $7,106
-14,212 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$0.41 - $0.63 $1,640 - $2,520
4,000 Added 39.17%
14,212 $8,000
Q4 2021

Feb 14, 2022

SELL
$0.57 - $1.29 $1,994 - $4,515
-3,500 Reduced 25.53%
10,212 $6,000
Q2 2021

Aug 16, 2021

BUY
$1.46 - $2.25 $20,019 - $30,852
13,712 New
13,712 $23,000

About TREVENA INC


  • Ticker TRVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 173,680,992
  • Market Cap $273M
  • Description
  • Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV...
More about TRVN
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.